Norway

Norway

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.52 (0.45 - 0.60) 2019 Modelled IHME
0.52 (0.45 - 0.60) 2018 Modelled IHME
0.52 (0.45 - 0.60) 2017 Modelled IHME
0.54 (0.47 - 0.62) 2016 Modelled IHME
0.57 (0.49 - 0.65) 2015 Modelled IHME
0.58 (0.50 - 0.66) 2014 Modelled IHME
0.59 (0.51 - 0.68) 2013 Modelled IHME
0.6 (0.52 - 0.69) 2012 Modelled IHME
0.61 (0.53 - 0.70) 2011 Modelled IHME
0.62 (0.54 - 0.71) 2010 Modelled IHME
0.63 (0.55 - 0.72) 2009 Modelled IHME
0.65 (0.56 - 0.74) 2008 Modelled IHME
0.66 (0.57 - 0.75) 2007 Modelled IHME
0.67 (0.58 - 0.76) 2006 Modelled IHME
0.68 (0.58 - 0.77) 2005 Modelled IHME
0.68 (0.59 - 0.77) 2004 Modelled IHME
0.69 (0.59 - 0.78) 2003 Modelled IHME
0.69 (0.60 - 0.78) 2002 Modelled IHME
0.69 (0.60 - 0.79) 2001 Modelled IHME
0.7 (0.60 - 0.79) 2000 Modelled IHME
0.7 (0.61 - 0.80) 1999 Modelled IHME
0.7 (0.61 - 0.80) 1998 Modelled IHME
0.71 (0.61 - 0.80) 1997 Modelled IHME
0.71 (0.62 - 0.81) 1996 Modelled IHME
0.72 (0.62 - 0.81) 1995 Modelled IHME
0.72 (0.63 - 0.82) 1994 Modelled IHME
0.72 (0.63 - 0.82) 1993 Modelled IHME
0.73 (0.63 - 0.83) 1992 Modelled IHME
0.73 (0.63 - 0.84) 1991 Modelled IHME
0.74 (0.63 - 0.84) 1990 Modelled IHME
0.01 (0 - 0.03) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.03 - 0.04) 2019 Modelled IHME
0.03 (0.03 - 0.04) 2018 Modelled IHME
0.03 (0.03 - 0.04) 2017 Modelled IHME
0.04 (0.03 - 0.05) 2016 Modelled IHME
0.04 (0.03 - 0.05) 2015 Modelled IHME
0.04 (0.03 - 0.05) 2014 Modelled IHME
0.04 (0.03 - 0.05) 2013 Modelled IHME
0.04 (0.03 - 0.05) 2012 Modelled IHME
0.04 (0.03 - 0.06) 2011 Modelled IHME
0.05 (0.03 - 0.06) 2010 Modelled IHME
0.05 (0.04 - 0.06) 2009 Modelled IHME
0.05 (0.04 - 0.07) 2008 Modelled IHME
0.05 (0.04 - 0.07) 2007 Modelled IHME
0.06 (0.04 - 0.08) 2006 Modelled IHME
0.06 (0.05 - 0.08) 2005 Modelled IHME
0.1 (0.07 - 0.12) 2004 Modelled IHME
0.16 (0.12 - 0.20) 2003 Modelled IHME
0.23 (0.18 - 0.30) 2002 Modelled IHME
0.3 (0.22 - 0.37) 2001 Modelled IHME
0.32 (0.25 - 0.41) 2000 Modelled IHME
0.33 (0.25 - 0.41) 1999 Modelled IHME
0.33 (0.25 - 0.42) 1998 Modelled IHME
0.33 (0.25 - 0.42) 1997 Modelled IHME
0.33 (0.25 - 0.42) 1996 Modelled IHME
0.34 (0.25 - 0.42) 1995 Modelled IHME
0.34 (0.25 - 0.42) 1994 Modelled IHME
0.34 (0.25 - 0.43) 1993 Modelled IHME
0.34 (0.25 - 0.43) 1992 Modelled IHME
0.34 (0.26 - 0.43) 1991 Modelled IHME
0.34 (0.26 - 0.43) 1990 Modelled IHME
0.01 (0 - 0.03) 2015 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.1 (0 - 0.30) 2004 Survey/reported Kristiansen MG et al, 2009

Number of people living with chronic HBV

National
Download
Value Year Type Source
31,266 (26,936 - 35,784) 1990 Modelled IHME
31,235 (27,044 - 35,696) 1991 Modelled IHME
31,203 (27,059 - 35,568) 1992 Modelled IHME
31,177 (27,053 - 35,516) 1993 Modelled IHME
31,159 (27,083 - 35,501) 1994 Modelled IHME
31,151 (27,027 - 35,427) 1995 Modelled IHME
31,147 (27,002 - 35,408) 1996 Modelled IHME
31,142 (27,032 - 35,358) 1997 Modelled IHME
31,138 (26,976 - 35,369) 1998 Modelled IHME
31,142 (26,951 - 35,419) 1999 Modelled IHME
31,150 (26,985 - 35,438) 2000 Modelled IHME
31,163 (26,960 - 35,383) 2001 Modelled IHME
31,182 (26,961 - 35,398) 2002 Modelled IHME
31,203 (26,979 - 35,414) 2003 Modelled IHME
31,214 (26,981 - 35,442) 2004 Modelled IHME
31,200 (26,997 - 35,478) 2005 Modelled IHME
31,103 (26,916 - 35,377) 2006 Modelled IHME
30,913 (26,776 - 35,170) 2007 Modelled IHME
30,685 (26,545 - 34,972) 2008 Modelled IHME
30,466 (26,338 - 34,765) 2009 Modelled IHME
30,290 (26,163 - 34,596) 2010 Modelled IHME
30,182 (26,062 - 34,389) 2011 Modelled IHME
30,097 (25,990 - 34,277) 2012 Modelled IHME
29,974 (25,859 - 34,132) 2013 Modelled IHME
29,747 (25,628 - 33,806) 2014 Modelled IHME
29,353 (25,337 - 33,396) 2015 Modelled IHME
28,248 (24,387 - 32,214) 2016 Modelled IHME
27,486 (23,748 - 31,497) 2017 Modelled IHME
27,687 (23,858 - 31,679) 2018 Modelled IHME
27,897 (24,023 - 31,859) 2019 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (10 - 15) 2019 Modelled IHME
12 (10 - 15) 2018 Modelled IHME
12 (10 - 15) 2017 Modelled IHME
13 (10 - 15) 2016 Modelled IHME
13 (11 - 15) 2015 Modelled IHME
13 (11 - 15) 2014 Modelled IHME
13 (11 - 16) 2013 Modelled IHME
13 (11 - 16) 2012 Modelled IHME
14 (11 - 16) 2011 Modelled IHME
14 (12 - 16) 2010 Modelled IHME
14 (11 - 16) 2009 Modelled IHME
14 (11 - 16) 2008 Modelled IHME
13 (11 - 16) 2007 Modelled IHME
13 (11 - 16) 2006 Modelled IHME
14 (11 - 16) 2005 Modelled IHME
13 (11 - 16) 2004 Modelled IHME
14 (11 - 16) 2003 Modelled IHME
14 (11 - 16) 2002 Modelled IHME
14 (11 - 16) 2001 Modelled IHME
14 (11 - 16) 2000 Modelled IHME
14 (12 - 16) 1999 Modelled IHME
14 (12 - 16) 1998 Modelled IHME
14 (12 - 16) 1997 Modelled IHME
14 (12 - 16) 1996 Modelled IHME
14 (12 - 17) 1995 Modelled IHME
14 (12 - 17) 1994 Modelled IHME
14 (12 - 17) 1993 Modelled IHME
14 (12 - 17) 1992 Modelled IHME
14 (12 - 17) 1991 Modelled IHME
14 (12 - 17) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
332 2017 Survey/reported EMCDDA, 2019
298 (247 - 350) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.91 (0.74 - 1.12) 2019 Modelled IHME
0.91 (0.74 - 1.12) 2018 Modelled IHME
0.91 (0.74 - 1.12) 2017 Modelled IHME
0.89 (0.72 - 1.09) 2016 Modelled IHME
0.87 (0.70 - 1.06) 2015 Modelled IHME
0.87 (0.70 - 1.06) 2014 Modelled IHME
0.87 (0.70 - 1.06) 2013 Modelled IHME
0.87 (0.70 - 1.06) 2012 Modelled IHME
0.87 (0.70 - 1.06) 2011 Modelled IHME
0.87 (0.70 - 1.06) 2010 Modelled IHME
0.86 (0.70 - 1.05) 2009 Modelled IHME
0.85 (0.68 - 1.03) 2008 Modelled IHME
0.83 (0.67 - 1.01) 2007 Modelled IHME
0.81 (0.66 - 0.99) 2006 Modelled IHME
0.8 (0.65 - 0.98) 2005 Modelled IHME
0.8 (0.64 - 0.97) 2004 Modelled IHME
0.79 (0.64 - 0.97) 2003 Modelled IHME
0.79 (0.64 - 0.96) 2002 Modelled IHME
0.78 (0.63 - 0.96) 2001 Modelled IHME
0.78 (0.63 - 0.96) 2000 Modelled IHME
0.78 (0.63 - 0.96) 1999 Modelled IHME
0.78 (0.63 - 0.96) 1998 Modelled IHME
0.79 (0.63 - 0.96) 1997 Modelled IHME
0.79 (0.64 - 0.97) 1996 Modelled IHME
0.79 (0.64 - 0.97) 1995 Modelled IHME
0.8 (0.64 - 0.98) 1994 Modelled IHME
0.81 (0.66 - 0.99) 1993 Modelled IHME
0.83 (0.67 - 1.01) 1992 Modelled IHME
0.85 (0.69 - 1.04) 1991 Modelled IHME
0.87 (0.71 - 1.07) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.7 (0.60 - 0.90) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
63 (61.80 - 64.20) 2013 Survey/reported EMCDDA
64.8 (60.40 - 69.10) 2012 Modelled Degenhardt L et al, 2017
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.9 (0.50 - 1.50) 2004 Survey/reported Kristiansen MG et al, 2009

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
37,052 (30,050 - 45,257) 1990 Modelled IHME
36,240 (29,386 - 44,418) 1991 Modelled IHME
35,506 (28,825 - 43,492) 1992 Modelled IHME
34,916 (28,293 - 42,820) 1993 Modelled IHME
34,539 (27,872 - 42,291) 1994 Modelled IHME
34,440 (27,744 - 42,106) 1995 Modelled IHME
34,513 (27,801 - 42,254) 1996 Modelled IHME
34,608 (27,885 - 42,402) 1997 Modelled IHME
34,731 (27,997 - 42,563) 1998 Modelled IHME
34,890 (28,142 - 42,747) 1999 Modelled IHME
35,084 (28,313 - 42,934) 2000 Modelled IHME
35,327 (28,502 - 43,214) 2001 Modelled IHME
35,636 (28,787 - 43,654) 2002 Modelled IHME
36,016 (29,139 - 44,117) 2003 Modelled IHME
36,462 (29,527 - 44,646) 2004 Modelled IHME
36,965 (29,897 - 45,256) 2005 Modelled IHME
37,737 (30,583 - 46,220) 2006 Modelled IHME
38,859 (31,501 - 47,614) 2007 Modelled IHME
40,120 (32,513 - 49,115) 2008 Modelled IHME
41,290 (33,449 - 50,626) 2009 Modelled IHME
42,107 (34,086 - 51,660) 2010 Modelled IHME
42,654 (34,607 - 52,275) 2011 Modelled IHME
43,194 (35,062 - 52,877) 2012 Modelled IHME
43,723 (35,498 - 53,546) 2013 Modelled IHME
44,234 (35,876 - 54,272) 2014 Modelled IHME
44,728 (36,212 - 54,872) 2015 Modelled IHME
46,437 (37,709 - 56,912) 2016 Modelled IHME
48,120 (38,891 - 59,090) 2017 Modelled IHME
48,495 (39,193 - 59,529) 2018 Modelled IHME
48,717 (39,429 - 59,829) 2019 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
42 (38 - 47) 2019 Modelled IHME
43 (39 - 47) 2018 Modelled IHME
43 (39 - 47) 2017 Modelled IHME
43 (39 - 47) 2016 Modelled IHME
42 (39 - 47) 2015 Modelled IHME
42 (38 - 46) 2014 Modelled IHME
42 (38 - 46) 2013 Modelled IHME
42 (38 - 46) 2012 Modelled IHME
42 (38 - 46) 2011 Modelled IHME
42 (38 - 46) 2010 Modelled IHME
42 (38 - 46) 2009 Modelled IHME
42 (38 - 46) 2008 Modelled IHME
42 (38 - 47) 2007 Modelled IHME
42 (39 - 46) 2006 Modelled IHME
42 (39 - 46) 2005 Modelled IHME
43 (39 - 47) 2004 Modelled IHME
43 (39 - 47) 2003 Modelled IHME
43 (39 - 47) 2002 Modelled IHME
43 (39 - 47) 2001 Modelled IHME
43 (39 - 47) 2000 Modelled IHME
43 (39 - 47) 1999 Modelled IHME
43 (39 - 47) 1998 Modelled IHME
43 (39 - 47) 1997 Modelled IHME
43 (39 - 47) 1996 Modelled IHME
43 (39 - 47) 1995 Modelled IHME
43 (39 - 47) 1994 Modelled IHME
43 (39 - 47) 1993 Modelled IHME
43 (38 - 47) 1992 Modelled IHME
43 (39 - 47) 1991 Modelled IHME
43 (39 - 47) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 2017 Survey/reported EMCDDA, 2019
298 (247 - 350) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.52 (%)
2019
(0.45 - 0.6(%))
IHME
HCV (RNA/cAg+)
0.91 (%)
2019
(0.74 - 1.12(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
52
2019
(44 - 59)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
159
2019
(139 - 177)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.03 (%)
2019, latest modelled
(0.03 - 0.04(%))
IHME

Prevalence PWID

HCV
63 (%)
2013, survey/surveillance
(61.80 - 64.20(%))
EMCDDA

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
332
2017
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines